Profile and Organization

Names, Facts, Figures about Bayer

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.

The Bayer Cross is one of the world´s best-known trademarks
The Bayer Cross is one of the world´s best-known trademarks

A growing and aging world population requires an adequate supply of food and improved medical care. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.

Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose:

 

tagline_bright-pink_600_1.png

 

Exclusive Focus on the Life Science Businesses

The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science. The Enabling Functions support the operational business. In 2020, the Bayer Group comprised 385 consolidated companies in 83 countries.

 

Structure of the Bayer Group

Board of ManagementCrop Science PharmaceuticalsConsumer HealthEnabling functions

 

Organization chart with management structure and fields of activity (PDF, 351.8 KB)

 

Business Operations Are the Responsibility of the Divisions:

ph-content180x120.jpgThe Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.

 

ch-content180x120.jpg The Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu categories.

 

 

orga_crop_science.jpg The Crop Science Division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture. The Environmental Science operating unit provides products and services for professional nonagricultural applications, such as vector and pest control and forestry.

 

Central Service Functions:

businesswoman_with_colleagues-180x120.jpg

The Enabling Functions operate as Group-wide competence centers in which business support services are bundled.

 

 

 

 

Corporate Governance

Dual governance system with the following governance bodies:

 

Board of Management: five members, Chairman: Werner Baumann
Supervisory Board: 20 members, Chairman: Prof. Dr. Norbert Winkeljohann

 

Locations

The Bayer Group comprises 385 consolidated companies** in 83 countries. Global headquarters are in Leverkusen, Germany.

  • **. fully consolidated subsidiaries (as of December. 31, 2020)

Our Employees

On December 31, 2020, Bayer employed 99,538 (2019: 103,824) people worldwide. In Germany we had 23,398 (2019: 24,953) employees, which was 23.5% of the total Bayer Group workforce (2019: 24.0%).

 

Employees by Region and Gender in 2020

 

employees

 

Read more about working at Bayer
Jobs and Career

 

Bayer Stock

 

Bayer Group Key Data
Bayer Group 2019 2020 Change
  € million € million %
Sales 43,545 41,400 -4.93
EBIT1 4,162 -16,169 -488.49
EBIT before special items2 6,975 7,095 1.72
EBITDA3 9,529 -2,910 -130.54
EBITDA before special items2 11,474 11,461 -0.11
EBITDA margin before special items (in %)4 26.3 27.7 5.32
Income before income taxes 2,853 -17,250 -704.63
Net income 4,091 -10,495 -356.54
Earnings per share (€)5 4.17 -10.68 -356.12
Core earnings per share (€)6 6.38 6.39 0.16
Net financial debt 34,068 30,041 -11.82
Capital expenditures as per segment table 2,920 3,138 7.47
Research and development expenses 5,301 7,126 34.43
Dividend per Bayer AG share (€) 2,80 2,00 -28,57

figures restated
1-6 for definition see footnotes to alternative performance measures Bayer Group (as of Dec. 31, 2020)